Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.

Rachel RieraÂngela Maria BagattiniRafael Leite PachecoDaniela Vianna PachitoFelipe RoitbergGerald W Prager

Published in: JCO global oncology (2021)

The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.

Keyphrases

healthcare
systematic review
meta analyses
coronavirus disease
sars cov
adverse drug
papillary thyroid
squamous cell
randomized controlled trial
risk factors
emergency department
lymph node metastasis
health information
drug induced